Margus Viigimaa
Tallinn, Estonia
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 71 publications
Evolocumab and risk of first myocardial infarction: the VESALIUS-CV trial.
Journal: European heart journal
Published: July 07, 2026
Pragmatic trial assessing polygenic risk driven statin therapy for cardiovascular disease prevention: study protocol for the EE-PRS trial.
Journal: BMJ open
Published: May 27, 2026
Evolocumab in Patients With Prior Percutaneous Coronary Intervention and No Prior Myocardial Infarction: Results From the VESALIUS-CV Trial.
Journal: Circulation
Published: May 19, 2026
Stroke prevention in the Americas: from knowing to doing.
Journal: Lancet regional health. Americas
Published: April 01, 2026
Lipid clinics worldwide: harmonization and guidance on how to optimally organize and fund. European Atherosclerosis Society consensus statement across 55 countries and more than 500 lipid clinics.
Journal: Atherosclerosis
Published: March 18, 2026
Hypertension in autoimmune rheumatic diseases: a position paper from the European Society of Hypertension working group on small arteries. Part A: pathophysiology, prevalence and cardiovascular risk estimation.
Journal: Journal of hypertension
Published: November 28, 2025
Hypertension in autoimmune rheumatic diseases - a position paper from the European Society of Hypertension working group on small arteries. Part B: Recommendations for the clinical management of hypertension.
Journal: Journal of hypertension
Published: November 28, 2025
Global survey of genetic testing methods for familial hypercholesterolemia. A study and recommendations from the EAS FHSC registry.
Journal: European journal of preventive cardiology
Published: October 30, 2025
The European Program for Prevention (EPP) - Implementing Proven Preventing Measures Now!
Journal: Global heart
Published: October 24, 2025
Lipid management for primary and secondary stroke prevention consensus paper of the International Lipid Expert Panel (ILEP).
Journal: Progress in cardiovascular diseases
Published: October 19, 2025
Evaluating the impact of communicating high polygenic risk for coronary artery disease on the health behaviour of young overweight adults: a pragmatic randomised controlled trial.
Journal: Scientific reports
Published: October 08, 2025
Last Updated: 09/26/2026